Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Debt / NOTE 4/0
-
Number of holders
-
55
-
Total 13F principal, excl. options
-
589,177,000
-
Principal change
-
-1,663,000
-
Total reported value, excl. options
-
$608,248,104
-
Value change
-
+$385,167
-
Number of buys
-
22
-
Number of sells
-
-26
-
Price
-
$1.03
Significant Holders of IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q2 2024
65 filings reported holding 462222AD2 - IONIS PHARMACEUTICALS INC - NOTE 4/0 as of Q2 2024.
IONIS PHARMACEUTICALS INC - NOTE 4/0 has 55 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $589,177,000 of principal
.
Largest 10 bondholders include TENOR CAPITAL MANAGEMENT Co., L.P. ($65,500,000 of principal), STEELHEAD PARTNERS LLC ($50,000,000 of principal), LAZARD ASSET MANAGEMENT LLC ($47,289,000 of principal), CITADEL ADVISORS LLC ($45,880,000 of principal), CAPSTONE INVESTMENT ADVISORS, LLC ($34,950,000 of principal), CSS LLC/IL ($31,931,000 of principal), MACKAY SHIELDS LLC ($30,020,000 of principal), Nuveen Asset Management, LLC ($26,500,000 of principal), CAMDEN ASSET MANAGEMENT L P /CA ($20,475,000 of principal), and SHENKMAN CAPITAL MANAGEMENT INC ($20,427,000 of principal).
This table shows the top 55 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.